Compare ANL & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | AHG |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | | Business Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.8M | 1.1B |
| IPO Year | 2022 | 2017 |
| Metric | ANL | AHG |
|---|---|---|
| Price | $10.00 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $29.50 | N/A |
| AVG Volume (30 Days) | ★ 229.1K | 7.1K |
| Earning Date | 08-14-2026 | 07-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $243.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $0.68 |
| 52 Week High | $17.25 | $2.50 |
| Indicator | ANL | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 53.54 |
| Support Level | $8.95 | $1.14 |
| Resistance Level | $11.75 | $1.46 |
| Average True Range (ATR) | 1.03 | 0.08 |
| MACD | 0.20 | -0.01 |
| Stochastic Oscillator | 42.35 | 63.44 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.